A simple and reproducible method for collecting nasal secretions in frail elderly adults, for measurement of virus-specific IgA

Journal of Infectious Diseases

Volumn 179, Issue 5, 1999, Pages 1268-1273

  Walsh, Edward E ^a,b   Falsey, Ann R ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b ROCHESTER GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A;

AGED; ANTIGEN SPECIFICITY; ARTICLE; ENZYME IMMUNOASSAY; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; NOSE SECRETION; NOSE SMEAR; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VIRUS INFECTION;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; FRAIL ELDERLY; HUMANS; IMMUNITY, MUCOSAL; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN A, SECRETORY; MIDDLE AGED; NASAL MUCOSA; REPRODUCIBILITY OF RESULTS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING;

EID: 0033010351     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314726     Document Type: Article

References (15)

1. 1. Treanor JJ, Mattison HR, Dumyati G, et al. Protective efficacy of combined live intranasal and inactivated influenza A virus vaccines in the elderly. Ann Intern Med 1992;117:625-33.
2. 2. Smith CB, Purcell RH, Bellanti JA, Chanock RM. Protective effect of antibody to parainfluenza type 1 virus. N Engl J Med 1966:275:1145-50.
3. 3. Renegar KB, Small PA. Passive transfer of local immunity to influenza virus infection by IgA antibody. J Immunol 1991;146:1972-9.
4. 4. Mills J, Van Kirk J, Wright PF, Chanock RM. Experimental respiratory syncytial virus infection of adults: possible mechanisms of resistance to infection and illness. J Immunol 1971;107:123-30.
5. 5. Watt P, Robinson B, Pringle C, Tyrell D. Determinants of the susceptibility to challenge and the antibody response of adult volunteers given experimental respiratory syncytial virus vaccine. Vaccine 1990;8:231-6.
6. 6. Falsey AR, Treanor JJ, Betts RF, Walsh EE. Viral respiratory infections in the institutionalized elderly: clinical and epidemiologic findings. J Am Geriatr Soc 1992;40:115-9.
7. 7. Falsey AR, Cunningham CK, Barker WH, et al. Respiratory syncytial virus and influenza A infections in the hospitalized elderly J Infect Dis 1995; 172:389-94.
8. 8. Dowell SF, Anderson LJ, Gary HEJ, et al. Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults. J Infect Dis 1996;174:456-62.
9. 9. Hall CB. Clinically useful method for the isolation of respiratory syncytial virus. J Infect Dis 1975;131:1-5.
10. 10. Powers DC, Murphy BR, Fries LF, Adler WH, Clements ML. Reduced infectivity of cold adapted influenza A HINI viruses in the elderly: correlation with serum and local antibodies. J Am Geriatr Soc 1992;40:163-7.
11. 11. Bergquist C, Johansson E, Lagergard T, Holmgren J, Rudin A. Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina. Infect Immun 1997;65:2676-84.
12. 12. Falsey AR, McCann RM, Hall WJ, et al. Acute respiratory tract infection in daycare centers for older persons. J Am Geriatr Soc 1995;43:30-6.
13. 13. Walsh EE, Schlesinger JJ, Brandriss M. Purification and characterization of GP90, one of the envelope glycoproteins of respiratory syncytial virus. J Gen Virol 1984;65:761-7.
14. 14. Walsh EE, Brandriss MW, Schlesinger JJ. Purification and characterization of the respiratory syncytial virus fusion protein. J Gen Virol 1985;66: 409-15.
15. 15. Gorse GJ, Otto EE, Powers DC, Chambers GW, Eickhoff CS, Newman FK. Induction of mucosal antibodies by live attenuated and inactivated influenza virus vaccines in the chronically ill elderly. J Infect Dis 1996;173: 285-90.